WMSA
BSX icon

Weiss Multi-Strategy Advisers’s Boston Scientific BSX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-52,500
Closed -$2.03M – 599
2022
Q3 		$2.03M Buy
+52,500
New +$2.11M 0.05% 396
2014
Q3 		– Sell
-42,400
Closed -$541K – 546
2014
Q2 		$541K Buy
+42,400
New +$551K 0.01% 513

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Weiss Multi-Strategy Advisers's BSX Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Boston Scientific (BSX) in Q1 2024, closing a stake of 178,254 shares — an estimated $10.3M sold.

Weiss Multi-Strategy Advisers first reported a position in BSX in Q4 2013 and held it in 41 quarters. The position peaked at $15.7M in Q2 2023. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Boston Scientific position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 178,254 Boston Scientific shares in Q1 2024, an estimated $10.3M.
  • Weiss Multi-Strategy Advisers first reported a position in Boston Scientific in Q4 2013 and held it in 41 quarters.
  • Weiss Multi-Strategy Advisers's Boston Scientific position peaked at $15.7M in Q2 2023.
  • 1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.